The Alfred E. Mann Foundation for Scientific Research (AMF) today announced the sale of intellectual property to Medtronic (NYSE:MDT). As part of the transaction of IP related to implanted infusion pumps, AMF will work with Medtronic to develop the technology into a next-generation implantable insulin pump for people living with hard-to-treat type 1 diabetes in Europe. Get […]
Medtronic
Medtronic CFO Karen Parkhill honored for financial excellence
Medtronic CFO Karen Parkhill has been named as an outstanding finance executive by the Minneapolis/St. Paul Business Journal in Minnesota. Parkhill is one of 14 individuals who will be honored in the newspaper’s 2021 CFO of the Year awards in November. She was one of two winners in the public company category, joined by Piper […]
Court denies injuction in Medtronic’s non-compete suit against former Medicrea CEO
A federal court in New York has denied Medtronic a preliminary injunction in its non-compete-agreement lawsuit against former Medicrea CEO Joseph Walland. Judge Edgardo Ramos of the U.S. District Court of Southern New York, in a Sept. 10 order, ruled that the agreement between Walland and Medtronic was covered by the law in California, where […]
Axonics loses IP challenge to Medtronic patents
Medtronic (NYSE:MDT) announced that it picked up three victories in an intellectual property (IP) dispute against Axonics (NSDQ:AXNX) over sacral neuromodulation devices. According to a news release, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) rejected Axonics’ attempt to invalidate three Medtronic patents in its IP infringement lawsuit related to Medtronic’s […]
Medtronic builds suspense for renal denervation study results
Medtronic’s clinical study of its Symplicity Spyral renal denervation system for hypertension is likely to go down to the wire for inclusion as a late-breaking clinical trial at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) conference. The highly anticipated results will offer new insight into the Fridley, Minnesota-based medical device manufacturer’s quest to build a billion-dollar […]
Corin Group picks head of Medtronic’s spine business as its CEO
Corin Group announced today that it appointed former Medtronic executive Jacob Paul as its new CEO. Cirencester, U.K.–based Corin Group said in a news release that Paul “brings unparalleled strategic and operational experience” to the company and is “well placed” to lead it through the next phase of its mission to improve patient activity and […]
Medtronic and Stasis announce patient monitoring partnership in India
Medtronic’s (NYSE:MDT) India-based subsidiary announced a strategic partnership with Stasis Health and its AI-based bedside monitoring system. India Medtronic Private Limited and Stasis Health (a wholly-owned subsidiary of Stasis Labs) partnered to scale up and expand access to the Stasis Monitor, a connected care bedside multi-parameter monitoring system, according to a news release. The Stasis […]
MedTech 100 roundup: Industry reaches another high point
The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. […]
Medtronic touts real-world data for Micra leadless pacemaker
Medtronic (NYSE:MDT) today touted data demonstrating reductions in reinterventions and complications with its Micra pacemaker. Fridley, Minn.-based Medtronic’s Micra Coverage with Evidence Development (CED) study, which it labeled the largest evaluation of leadless pacemakers to date, showed that the Micra transcatheter pacing system (TPS) was associated with a 38% reduction in reinterventions and a 31% […]
Medtronic CEO Geoff Martha touts progress on renal denervation and Hugo robotics
Medtronic (NYSE: MDT) is boosting its research and development spending in fiscal year 2022 by more than 10%, which CEO Geoff Martha described as the largest dollar increase ever for the Fridley, Minn.-based medtech giant. “The investments we’re making in our pipeline will play a key role in accelerating our top-line growth, and we’re at […]
FDA approves Medtronic next-gen Evolut FX TAVR system
Medtronic today announced that its Evolut FX TAVR system has won FDA approval. Fridley, Minn.–based Medtronic designed the self-expanding transcatheter aortic valve replacement system to treat symptomatic severe aortic stenosis. Get the full story on our sister site, Medical Tubing + Extrusion.